|Salary:||£32,817 to £40,322 Grade 7,p.a|
|Placed On:||7th April 2021|
|Closes:||17th May 2021|
We are seeking a highly motivated, academically excellent and proactive Postdoctoral Researcher with a strong background in innate immunity to join the Genomics of Inflammation group of Professor Irina Udalova at the University of Oxford, Kenney Institute of Rehumatology.
You will be carrying out research on the transcriptional and molecular control of inflammatory and immunometabolic diseases, within a leading-edge international consortium (Oxford-Copenhagen-Stockholm) funded by Novo Nordisk Foundation. You will be using unique in vivo models, advanced immunological and imaging approaches and innovative single cell genomic technologies to study how function of innate immune cells is guided by intrinsic molecular regulators and influenced by extrinsic protein, lipid and metabolic signals. You will benefit from a portfolio of mechanistically-informed immuno-metabolic targets built by our consortium, which provides unprecedented opportunities to match substrate-specific alterations to cell-specific changes and disease pathogenetic.
You will join an interdisciplinary and international team of scientists and clinician researchers studying the contribution of the immune system in the pathogenesis of immunometabolic diseases. You will be based at the Kennedy Institute of Rheumatology, University of Oxford, which is a world-leading research centre where discovery research drives development of transformative therapies for chronic inflammatory and degenerative disease. You will have an opportunity to visit other research institutes of the consortium.
You will hold a PhD (or near completion) in immunology, molecular and cellular biology, or similar. You will demonstrate capacity to deliver high quality research outputs, illustrated by a strong publication record in high profile immunological journals. Expertise in neutrophil and/or macrophage biology, single cell and functional genomics approaches and in vivo models of immunometabolic diseases would be desirable.
This is a full-time appointment fixed-term for 2 years in the first instance.
You will be required to upload a supporting statement, CV and names of referees as part of your online application.
Due to the nature of the research at the Kennedy Institute of Rheumatology, this job will require additional security pre-employment checks:
• A satisfactory basic Disclosure and Barring Service check
• University security screening (eg identity checks)
The closing date for applications is 12.00 noon on Monday 17 May 2021.
Type / Role: